Prospettive Sociali e Sanitarie

Wade H. Berrettini and Caryn E. Lerman Pharmacotherapy and Pharmacogenetics of Nicotine Dependence 1441-1451
Kathleen M. Carroll and Lisa S. Onken Behavioral Therapies for Drug Abuse 1452-1460
Terry L. Jernigan, Anthony C. Gamst, Sarah L. Archibald, Christine Fennema-Notestine, Monica Rivera Mindt,
Thomas L. Marcotte, Robert K. Heaton, Ronald J. Ellis, and Igor Grant Effects of Methamphetamine Dependence and
HIV Infection on Cerebral Morphology 1461-1472
Michael A. Nader and Paul W. Czoty PET Imaging of Dopamine D2 Receptors in Monkey Models of Cocaine Abuse:
Genetic Predisposition Versus Environmental Modulation 1473-1482
Kathleen T. Brady and Rajita Sinha Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects
of Chronic Stress 1483-1493
Wilson M. Compton, Yonette F. Thomas, Kevin P. Conway, and James D. Colliver Developments in the Epidemiology
of Drug Use and Drug Use Disorders 1494-1502
Images in Neuroscience:Michael W. Vogel Cell Death 1503
Introspections:Paul Croarkin Group Therapy in a Combat Zone? 1504-381505
Images in Psychiatry:Vladimir Lerner and Eliezer Witztum Vladimir Bekhterev, 1857–1927 1506
New Research
Efrat Aharonovich, Xinhua Liu, Sharon Samet, Edward Nunes, Rachel Waxman, and Deborah Hasin
Postdischarge Cannabis Use and Its Relationship to Cocaine, Alcohol, and Heroin Use: A Prospective Study 1507-1514
Andreas Heinz, Thomas Siessmeier, Jana Wrase, Hans Georg Buchholz, Gerhard Gründer, Yoshitaka Kumakura, Paul
Cumming, Mathias Schreckenberger, Michael N. Smolka, Frank Rösch, Karl Mann, and Peter Bartenstein
Correlation of Alcohol Craving With Striatal Dopamine Synthesis Capacity and D2/3 Receptor Availability: A
Combined [18F]DOPA and [18F]DMFP PET Study in Detoxified Alcoholic Patients 1515-1520
Mayur M. Desai, Robert A. Rosenheck, and Thomas J. Craig
Screening for Alcohol Use Disorders Among Medical Outpatients: The Influence of Individual and Facility
Characteristics 1521-1526
Brief Reports:
Beng-Choon Ho, Daniel Alicata, Carmencita Mola, and Nancy C. Andreasen
Hippocampus Volume and Treatment Delays in First-Episode Schizophrenia 1527-1529
Neil P. Mills, Melissa P. DelBello, Caleb M. Adler, and Stephen M. Strakowski
MRI Analysis of Cerebellar Vermal Abnormalities in Bipolar Disorder 1530-1533
Yuri Rassovsky, Michael F. Green, Keith H. Nuechterlein, Bruno Breitmeyer, and Jim Mintz
Modulation of Attention During Visual Masking in Schizophrenia 1533-1535
George M. Simpson, Peter Weiden, Theresa Pigott, Stephen Murray, Cynthia O. Siu, and Steven J. Romano
Six-Month, Blinded, Multicenter Continuation Study of Ziprasidone Versus Olanzapine in Schizophrenia 1535-1538
Jay Nierenberg, Dean F. Salisbury, James J. Levitt, Elizabeth A. David, Robert W. McCarley, and Martha E. Shenton
Reduced Left Angular Gyrus Volume in First-Episode Schizophrenia 1539-1541
Communications and Updates
Letters to the Editor:
DANA KOBER and GLEN O. GABBARD Topiramate-Induced Psychosis 1542
REBECCA WAHL and ROBERT OSTROFF Reversal of Symptomatic Hyperprolactinemia by Aripiprazole 1542-1543
KENAN M. PENASKOVIC, SIDDHARTHA ANNAMRAJU, and JOHN E. KRAUS Clozapine-Induced Allergic
Vasculitis 1543-1542
RAYMOND BUNCH, MARSHALL THOMAS, and NORMAN BUNCH Smokeless Tobacco for a Nicotine-
Dependent Schizoaffective Patient 1543-1544
LIEUWE de HAAN, JULES LAVALAYE, JAN BOOIJ, and DON LINSZEN
Comfort, Self-Confidence, Safety, and Dopamine D2 Receptor Occupancy by Antipsychotics 1544-1545
VENKATASUBRAMANIAN GANESAN, MIKE D. HUNTER, and SEAN A. SPENCE Schneiderian First-Rank
Symptoms and Right Parietal Hyperactivation: A Replication Using fMRI 1545
S. NASSIR GHAEMI and FREDERICK K. GOODWIN Antidepressants for Bipolar Depression 1545-1546
JEFFREY C. FETTER and KATHLEEN D. ASKLAND Antidepressants for Bipolar Depression 1546